HEALTH● ELEVATED2h ago · Oct 28, 2026, 6:18 PM
HHS to allow sale of unapproved peptides under review
The Hill · north america
The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to those championed by the “Make America Healthy Again” (MAHA) agenda. The HHS stated in a notice that it would be practicing enforcement discretion…
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH34m agoTrial of surgeon Aníbal Lotocki: he is acquitted in three cases of serious injuries but continues with two othersClarínHEALTH35m agoHayden Panettiere's death ruled accidental by South Carolina policeCBS NewsHEALTH1h agoHow flu vaccination works in Russia, Germany, the U.K., and eight other countriesMeduza [en]HEALTH1h agoTexas officials investigate claims State Fair petting zoo was source of E. coli surgeThe Independent World